For Peter Pitts, a former associate commissioner at the FDA, the appointment to the board of BrainStorm Cell Therapeutics is ...
Former Senior FDA Official Joins Board as Company Prepares to Initiate Historic Phase 3b ALS Trial Under Special Protocol Assessment NEW YORK, May 28, 2026 /PRNewswire/ -- BrainStorm Cell ...
How often have you gone to a brainstorming session expecting fresh new ideas but being met with the same ideas from the last quarter? If this sounds like you, don’t despair. I’ve spent over a decade ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results